|
Delayed
Nasdaq Stockholm
14:43:45 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8380 SEK | +4.36% |
|
-6.89% | +1.09% |
| 08-20 | Alzinova AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | RX Securities reiterates buy on Alzinova, justified value SEK 3.50 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALZINOVA AB | Other Biotechnology & Medical Research | +4.36% | -6.89% | +1.09% | -47.30% | -89.12% | 17.15M |  | | |
- Stock Market
- Stocks
- ALZ Stock
- Charts Alzinova AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
